Global Oncology Biosimilars Market Research Report 2017

October 2017 | 100 pages | ID: GAC144D2A55PEN
QYResearch

Abstracts

In this report, the global Oncology Biosimilars market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Oncology Biosimilars in these regions, from 2012 to 2022 (forecast), covering

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Global Oncology Biosimilars market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

• Celltrion Inc.
• Pfizer Inc.
• Biocon
• BIOCAD
• Apotex Inc.
• Dr. Reddy's Laboratories Ltd.
• Sandoz International GmbH
• Intas Pharmaceuticals Ltd.
• STADA Arzneimittel AG
• Teva Pharmaceutical Industries Ltd.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• G-CSF
• Hematopoietic Agents
• Monoclonal Antibodies

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Oncology Biosimilars for each application, including

• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Oncology Biosimilars Market Research Report 2017

1 ONCOLOGY BIOSIMILARS MARKET OVERVIEW

1.1 Product Overview and Scope of Oncology Biosimilars
1.2 Oncology Biosimilars Segment by Type (Product Category)
  1.2.1 Global Oncology Biosimilars Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
  1.2.2 Global Oncology Biosimilars Production Market Share by Type (Product Category) in 2016
  1.2.3 G-CSF
  1.2.4 Hematopoietic Agents
  1.2.5 Monoclonal Antibodies
1.3 Global Oncology Biosimilars Segment by Application
  1.3.1 Oncology Biosimilars Consumption (Sales) Comparison by Application (2012-2022)
  1.3.2 Retail Pharmacies
  1.3.3 Hospital Pharmacies
  1.3.4 Online Pharmacies
1.4 Global Oncology Biosimilars Market by Region (2012-2022)
  1.4.1 Global Oncology Biosimilars Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
  1.4.2 North America Status and Prospect (2012-2022)
  1.4.3 Europe Status and Prospect (2012-2022)
  1.4.4 China Status and Prospect (2012-2022)
  1.4.5 Japan Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Status and Prospect (2012-2022)
  1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Oncology Biosimilars (2012-2022)
  1.5.1 Global Oncology Biosimilars Revenue Status and Outlook (2012-2022)
  1.5.2 Global Oncology Biosimilars Capacity, Production Status and Outlook (2012-2022)

2 GLOBAL ONCOLOGY BIOSIMILARS MARKET COMPETITION BY MANUFACTURERS

2.1 Global Oncology Biosimilars Capacity, Production and Share by Manufacturers (2012-2017)
  2.1.1 Global Oncology Biosimilars Capacity and Share by Manufacturers (2012-2017)
  2.1.2 Global Oncology Biosimilars Production and Share by Manufacturers (2012-2017)
2.2 Global Oncology Biosimilars Revenue and Share by Manufacturers (2012-2017)
2.3 Global Oncology Biosimilars Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Oncology Biosimilars Manufacturing Base Distribution, Sales Area and Product Type
2.5 Oncology Biosimilars Market Competitive Situation and Trends
  2.5.1 Oncology Biosimilars Market Concentration Rate
  2.5.2 Oncology Biosimilars Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL ONCOLOGY BIOSIMILARS CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

3.1 Global Oncology Biosimilars Capacity and Market Share by Region (2012-2017)
3.2 Global Oncology Biosimilars Production and Market Share by Region (2012-2017)
3.3 Global Oncology Biosimilars Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Oncology Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Oncology Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Oncology Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Oncology Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Oncology Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Oncology Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Oncology Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 GLOBAL ONCOLOGY BIOSIMILARS SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGION (2012-2017)

4.1 Global Oncology Biosimilars Consumption by Region (2012-2017)
4.2 North America Oncology Biosimilars Production, Consumption, Export, Import (2012-2017)
4.3 Europe Oncology Biosimilars Production, Consumption, Export, Import (2012-2017)
4.4 China Oncology Biosimilars Production, Consumption, Export, Import (2012-2017)
4.5 Japan Oncology Biosimilars Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Oncology Biosimilars Production, Consumption, Export, Import (2012-2017)
4.7 India Oncology Biosimilars Production, Consumption, Export, Import (2012-2017)

5 GLOBAL ONCOLOGY BIOSIMILARS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Oncology Biosimilars Production and Market Share by Type (2012-2017)
5.2 Global Oncology Biosimilars Revenue and Market Share by Type (2012-2017)
5.3 Global Oncology Biosimilars Price by Type (2012-2017)
5.4 Global Oncology Biosimilars Production Growth by Type (2012-2017)

6 GLOBAL ONCOLOGY BIOSIMILARS MARKET ANALYSIS BY APPLICATION

6.1 Global Oncology Biosimilars Consumption and Market Share by Application (2012-2017)
6.2 Global Oncology Biosimilars Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL ONCOLOGY BIOSIMILARS MANUFACTURERS PROFILES/ANALYSIS

7.1 Celltrion Inc.
  7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.1.2 Oncology Biosimilars Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 Celltrion Inc. Oncology Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Main Business/Business Overview
7.2 Pfizer Inc.
  7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.2.2 Oncology Biosimilars Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 Pfizer Inc. Oncology Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Main Business/Business Overview
7.3 Biocon
  7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.3.2 Oncology Biosimilars Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 Biocon Oncology Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Main Business/Business Overview
7.4 BIOCAD
  7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.4.2 Oncology Biosimilars Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 BIOCAD Oncology Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Main Business/Business Overview
7.5 Apotex Inc.
  7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.5.2 Oncology Biosimilars Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 Apotex Inc. Oncology Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Main Business/Business Overview
7.6 Dr. Reddy?s Laboratories Ltd.
  7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.6.2 Oncology Biosimilars Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 Dr. Reddy?s Laboratories Ltd. Oncology Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Main Business/Business Overview
7.7 Sandoz International GmbH
  7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.7.2 Oncology Biosimilars Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 Sandoz International GmbH Oncology Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Main Business/Business Overview
7.8 Intas Pharmaceuticals Ltd.
  7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.8.2 Oncology Biosimilars Product Category, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 Intas Pharmaceuticals Ltd. Oncology Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Main Business/Business Overview
7.9 STADA Arzneimittel AG
  7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.9.2 Oncology Biosimilars Product Category, Application and Specification
    7.9.2.1 Product A
    7.9.2.2 Product B
  7.9.3 STADA Arzneimittel AG Oncology Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.9.4 Main Business/Business Overview
7.10 Teva Pharmaceutical Industries Ltd.
  7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.10.2 Oncology Biosimilars Product Category, Application and Specification
    7.10.2.1 Product A
    7.10.2.2 Product B
  7.10.3 Teva Pharmaceutical Industries Ltd. Oncology Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.10.4 Main Business/Business Overview

8 ONCOLOGY BIOSIMILARS MANUFACTURING COST ANALYSIS

8.1 Oncology Biosimilars Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Oncology Biosimilars

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Oncology Biosimilars Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Oncology Biosimilars Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL ONCOLOGY BIOSIMILARS MARKET FORECAST (2017-2022)

12.1 Global Oncology Biosimilars Capacity, Production, Revenue Forecast (2017-2022)
  12.1.1 Global Oncology Biosimilars Capacity, Production and Growth Rate Forecast (2017-2022)
  12.1.2 Global Oncology Biosimilars Revenue and Growth Rate Forecast (2017-2022)
  12.1.3 Global Oncology Biosimilars Price and Trend Forecast (2017-2022)
12.2 Global Oncology Biosimilars Production, Consumption, Import and Export Forecast by Region (2017-2022)
  12.2.1 North America Oncology Biosimilars Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.2 Europe Oncology Biosimilars Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.3 China Oncology Biosimilars Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.4 Japan Oncology Biosimilars Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.5 Southeast Asia Oncology Biosimilars Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.6 India Oncology Biosimilars Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Oncology Biosimilars Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Oncology Biosimilars Consumption Forecast by Application (2017-2022)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology/Research Approach
  14.1.1 Research Programs/Design
  14.1.2 Market Size Estimation
  14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
  14.2.1 Secondary Sources
  14.2.2 Primary Sources
14.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Oncology Biosimilars
Figure Global Oncology Biosimilars Production (MT) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Oncology Biosimilars Production Market Share by Types (Product Category) in 2016
Figure Product Picture of G-CSF
Table Major Manufacturers of G-CSF
Figure Product Picture of Hematopoietic Agents
Table Major Manufacturers of Hematopoietic Agents
Figure Product Picture of Monoclonal Antibodies
Table Major Manufacturers of Monoclonal Antibodies
Figure Global Oncology Biosimilars Consumption (MT) by Applications (2012-2022)
Figure Global Oncology Biosimilars Consumption Market Share by Applications in 2016
Figure Retail Pharmacies Examples
Table Key Downstream Customer in Retail Pharmacies
Figure Hospital Pharmacies Examples
Table Key Downstream Customer in Hospital Pharmacies
Figure Online Pharmacies Examples
Table Key Downstream Customer in Online Pharmacies
Figure Global Oncology Biosimilars Market Size (Million USD), Comparison (MT) and CAGR (%) by Regions (2012-2022)
Figure North America Oncology Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Oncology Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Oncology Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Oncology Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Oncology Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Oncology Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Oncology Biosimilars Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Oncology Biosimilars Capacity, Production (MT) Status and Outlook (2012-2022)
Figure Global Oncology Biosimilars Major Players Product Capacity (MT) (2012-2017)
Table Global Oncology Biosimilars Capacity (MT) of Key Manufacturers (2012-2017)
Table Global Oncology Biosimilars Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Oncology Biosimilars Capacity (MT) of Key Manufacturers in 2016
Figure Global Oncology Biosimilars Capacity (MT) of Key Manufacturers in 2017
Figure Global Oncology Biosimilars Major Players Product Production (MT) (2012-2017)
Table Global Oncology Biosimilars Production (MT) of Key Manufacturers (2012-2017)
Table Global Oncology Biosimilars Production Share by Manufacturers (2012-2017)
Figure 2016 Oncology Biosimilars Production Share by Manufacturers
Figure 2017 Oncology Biosimilars Production Share by Manufacturers
Figure Global Oncology Biosimilars Major Players Product Revenue (Million USD) (2012-2017)
Table Global Oncology Biosimilars Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Oncology Biosimilars Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Oncology Biosimilars Revenue Share by Manufacturers
Table 2017 Global Oncology Biosimilars Revenue Share by Manufacturers
Table Global Market Oncology Biosimilars Average Price (USD/Kg) of Key Manufacturers (2012-2017)
Figure Global Market Oncology Biosimilars Average Price (USD/Kg) of Key Manufacturers in 2016
Table Manufacturers Oncology Biosimilars Manufacturing Base Distribution and Sales Area
Table Manufacturers Oncology Biosimilars Product Category
Figure Oncology Biosimilars Market Share of Top 3 Manufacturers
Figure Oncology Biosimilars Market Share of Top 5 Manufacturers
Table Global Oncology Biosimilars Capacity (MT) by Region (2012-2017)
Figure Global Oncology Biosimilars Capacity Market Share by Region (2012-2017)
Figure Global Oncology Biosimilars Capacity Market Share by Region (2012-2017)
Figure 2016 Global Oncology Biosimilars Capacity Market Share by Region
Table Global Oncology Biosimilars Production by Region (2012-2017)
Figure Global Oncology Biosimilars Production (MT) by Region (2012-2017)
Figure Global Oncology Biosimilars Production Market Share by Region (2012-2017)
Figure 2016 Global Oncology Biosimilars Production Market Share by Region
Table Global Oncology Biosimilars Revenue (Million USD) by Region (2012-2017)
Table Global Oncology Biosimilars Revenue Market Share by Region (2012-2017)
Figure Global Oncology Biosimilars Revenue Market Share by Region (2012-2017)
Table 2016 Global Oncology Biosimilars Revenue Market Share by Region
Figure Global Oncology Biosimilars Capacity, Production (MT) and Growth Rate (2012-2017)
Table Global Oncology Biosimilars Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Table North America Oncology Biosimilars Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Table Europe Oncology Biosimilars Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Table China Oncology Biosimilars Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Table Japan Oncology Biosimilars Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Table Southeast Asia Oncology Biosimilars Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Table India Oncology Biosimilars Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Table Global Oncology Biosimilars Consumption (MT) Market by Region (2012-2017)
Table Global Oncology Biosimilars Consumption Market Share by Region (2012-2017)
Figure Global Oncology Biosimilars Consumption Market Share by Region (2012-2017)
Figure 2016 Global Oncology Biosimilars Consumption (MT) Market Share by Region
Table North America Oncology Biosimilars Production, Consumption, Import & Export (MT) (2012-2017)
Table Europe Oncology Biosimilars Production, Consumption, Import & Export (MT) (2012-2017)
Table China Oncology Biosimilars Production, Consumption, Import & Export (MT) (2012-2017)
Table Japan Oncology Biosimilars Production, Consumption, Import & Export (MT) (2012-2017)
Table Southeast Asia Oncology Biosimilars Production, Consumption, Import & Export (MT) (2012-2017)
Table India Oncology Biosimilars Production, Consumption, Import & Export (MT) (2012-2017)
Table Global Oncology Biosimilars Production (MT) by Type (2012-2017)
Table Global Oncology Biosimilars Production Share by Type (2012-2017)
Figure Production Market Share of Oncology Biosimilars by Type (2012-2017)
Figure 2016 Production Market Share of Oncology Biosimilars by Type
Table Global Oncology Biosimilars Revenue (Million USD) by Type (2012-2017)
Table Global Oncology Biosimilars Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Oncology Biosimilars by Type (2012-2017)
Figure 2016 Revenue Market Share of Oncology Biosimilars by Type
Table Global Oncology Biosimilars Price (USD/Kg) by Type (2012-2017)
Figure Global Oncology Biosimilars Production Growth by Type (2012-2017)
Table Global Oncology Biosimilars Consumption (MT) by Application (2012-2017)
Table Global Oncology Biosimilars Consumption Market Share by Application (2012-2017)
Figure Global Oncology Biosimilars Consumption Market Share by Applications (2012-2017)
Figure Global Oncology Biosimilars Consumption Market Share by Application in 2016
Table Global Oncology Biosimilars Consumption Growth Rate by Application (2012-2017)
Figure Global Oncology Biosimilars Consumption Growth Rate by Application (2012-2017)
Table Celltrion Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Celltrion Inc. Oncology Biosimilars Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Celltrion Inc. Oncology Biosimilars Production Growth Rate (2012-2017)
Figure Celltrion Inc. Oncology Biosimilars Production Market Share (2012-2017)
Figure Celltrion Inc. Oncology Biosimilars Revenue Market Share (2012-2017)
Table Pfizer Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Inc. Oncology Biosimilars Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Pfizer Inc. Oncology Biosimilars Production Growth Rate (2012-2017)
Figure Pfizer Inc. Oncology Biosimilars Production Market Share (2012-2017)
Figure Pfizer Inc. Oncology Biosimilars Revenue Market Share (2012-2017)
Table Biocon Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biocon Oncology Biosimilars Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Biocon Oncology Biosimilars Production Growth Rate (2012-2017)
Figure Biocon Oncology Biosimilars Production Market Share (2012-2017)
Figure Biocon Oncology Biosimilars Revenue Market Share (2012-2017)
Table BIOCAD Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table BIOCAD Oncology Biosimilars Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure BIOCAD Oncology Biosimilars Production Growth Rate (2012-2017)
Figure BIOCAD Oncology Biosimilars Production Market Share (2012-2017)
Figure BIOCAD Oncology Biosimilars Revenue Market Share (2012-2017)
Table Apotex Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Apotex Inc. Oncology Biosimilars Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Apotex Inc. Oncology Biosimilars Production Growth Rate (2012-2017)
Figure Apotex Inc. Oncology Biosimilars Production Market Share (2012-2017)
Figure Apotex Inc. Oncology Biosimilars Revenue Market Share (2012-2017)
Table Dr. Reddy?s Laboratories Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Dr. Reddy?s Laboratories Ltd. Oncology Biosimilars Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Dr. Reddy?s Laboratories Ltd. Oncology Biosimilars Production Growth Rate (2012-2017)
Figure Dr. Reddy?s Laboratories Ltd. Oncology Biosimilars Production Market Share (2012-2017)
Figure Dr. Reddy?s Laboratories Ltd. Oncology Biosimilars Revenue Market Share (2012-2017)
Table Sandoz International GmbH Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sandoz International GmbH Oncology Biosimilars Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Sandoz International GmbH Oncology Biosimilars Production Growth Rate (2012-2017)
Figure Sandoz International GmbH Oncology Biosimilars Production Market Share (2012-2017)
Figure Sandoz International GmbH Oncology Biosimilars Revenue Market Share (2012-2017)
Table Intas Pharmaceuticals Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Intas Pharmaceuticals Ltd. Oncology Biosimilars Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Intas Pharmaceuticals Ltd. Oncology Biosimilars Production Growth Rate (2012-2017)
Figure Intas Pharmaceuticals Ltd. Oncology Biosimilars Production Market Share (2012-2017)
Figure Intas Pharmaceuticals Ltd. Oncology Biosimilars Revenue Market Share (2012-2017)
Table STADA Arzneimittel AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table STADA Arzneimittel AG Oncology Biosimilars Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure STADA Arzneimittel AG Oncology Biosimilars Production Growth Rate (2012-2017)
Figure STADA Arzneimittel AG Oncology Biosimilars Production Market Share (2012-2017)
Figure STADA Arzneimittel AG Oncology Biosimilars Revenue Market Share (2012-2017)
Table Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva Pharmaceutical Industries Ltd. Oncology Biosimilars Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Teva Pharmaceutical Industries Ltd. Oncology Biosimilars Production Growth Rate (2012-2017)
Figure Teva Pharmaceutical Industries Ltd. Oncology Biosimilars Production Market Share (2012-2017)
Figure Teva Pharmaceutical Industries Ltd. Oncology Biosimilars Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oncology Biosimilars
Figure Manufacturing Process Analysis of Oncology Biosimilars
Figure Oncology Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of Oncology Biosimilars Major Manufacturers in 2016
Table Major Buyers of Oncology Biosimilars
Table Distributors/Traders List
Figure Global Oncology Biosimilars Capacity, Production (MT) and Growth Rate Forecast (2017-2022)
Figure Global Oncology Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Oncology Biosimilars Price (Million USD) and Trend Forecast (2017-2022)
Table Global Oncology Biosimilars Production (MT) Forecast by Region (2017-2022)
Figure Global Oncology Biosimilars Production Market Share Forecast by Region (2017-2022)
Table Global Oncology Biosimilars Consumption (MT) Forecast by Region (2017-2022)
Figure Global Oncology Biosimilars Consumption Market Share Forecast by Region (2017-2022)
Figure North America Oncology Biosimilars Production (MT) and Growth Rate Forecast (2017-2022)
Figure North America Oncology Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Oncology Biosimilars Production, Consumption, Export and Import (MT) Forecast (2017-2022)
Figure Europe Oncology Biosimilars Production (MT) and Growth Rate Forecast (2017-2022)
Figure Europe Oncology Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Oncology Biosimilars Production, Consumption, Export and Import (MT) Forecast (2017-2022)
Figure China Oncology Biosimilars Production (MT) and Growth Rate Forecast (2017-2022)
Figure China Oncology Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Oncology Biosimilars Production, Consumption, Export and Import (MT) Forecast (2017-2022)
Figure Japan Oncology Biosimilars Production (MT) and Growth Rate Forecast (2017-2022)
Figure Japan Oncology Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Oncology Biosimilars Production, Consumption, Export and Import (MT) Forecast (2017-2022)
Figure Southeast Asia Oncology Biosimilars Production (MT) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Oncology Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Oncology Biosimilars Production, Consumption, Export and Import (MT) Forecast (2017-2022)
Figure India Oncology Biosimilars Production (MT) and Growth Rate Forecast (2017-2022)
Figure India Oncology Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Oncology Biosimilars Production, Consumption, Export and Import (MT) Forecast (2017-2022)
Table Global Oncology Biosimilars Production (MT) Forecast by Type (2017-2022)
Figure Global Oncology Biosimilars Production (MT) Forecast by Type (2017-2022)
Table Global Oncology Biosimilars Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Oncology Biosimilars Revenue Market Share Forecast by Type (2017-2022)
Table Global Oncology Biosimilars Price Forecast by Type (2017-2022)
Table Global Oncology Biosimilars Consumption (MT) Forecast by Application (2017-2022)
Figure Global Oncology Biosimilars Consumption (MT) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source